Light Degradable Drug Delivery System For Effective Ocular Therapy
- 詳細技術說明
- University researchers have developed compositions and methods that enable light-triggered ocular drug delivery utilizing a polymer that degrades upon exposure to specific wavelength(s) of light.
- *Abstract
-
None
- *Principal Investigation
-
Name: Adah Almutairi
Department:
Name: Enas Mahmoud
Department:
Name: Cathryn McFearin
Department:
Name: Nguyen Huu
Department:
- 附加資料
- Inventor: ALMUTAIRI, Adah | ALMUTAIRI, Khalid
Priority Number: WO2013169955A1
IPC Current: A61N000500 | A61B001804 | B82Y000500
Assignee Applicant: The Regents of the University of California
Title: FINE SPATIOTEMPORAL CONTROL OF THERMOLYSIS AND LIPOLYSIS USING NIR LIGHT | RÉGLAGE SPATIO-TEMPOREL FIN DE LA THERMOLYSE ET DE LA LIPOYSE AU MOYEN D'UNE LUMIÈRE INFRAROUGE PROCHE
Usefulness: FINE SPATIOTEMPORAL CONTROL OF THERMOLYSIS AND LIPOLYSIS USING NIR LIGHT | RÉGLAGE SPATIO-TEMPOREL FIN DE LA THERMOLYSE ET DE LA LIPOYSE AU MOYEN D'UNE LUMIÈRE INFRAROUGE PROCHE
Summary: System for minimally-invasive lipolysis in a target area to remove fatty tissue using infrared laser light for a patient.
Novelty: System for minimally-invasive lipolysis in target area to remove of fatty tissue using infrared laser light for patient, has emission wavelength adapted to excite biocompatible nanoparticles to melt fat within target area
- 主要類別
- 診斷/治療
- 細分類別
- 其他疾病
- 其他
-
State Of Development
Proof of concept has been achieved through in vitro and in vivo experiments.
Intellectual Property Info
The invention has a patent pending and is available for licensing.
Related Cases
Tech ID/UC Case
23225/2012-355-0
Related Cases
2012-355-0
- 國家/地區
- 美國
欲了解更多信息,請點擊 這裡
